The purpose of this study is to document safety and efficacy of renal sympathetic denervation treatment in subjects with uncontrolled hypertension by using Iberis renal denervation system.
This study is a prospective, multi-center, single-arm, non-interventional and open-label registry to collect descriptive data from patients who receive renal sympathetic denervation treatment in accordance with routine hospital practice using Iberis system. This registry will collect data prospectively from patients that receive renal sympathetic denervation treatment with use of Iberis renal denervation system and treatment will be applied according to the routine hospital practice. No additional tests are required specific to this registry. The registry will serve as a tool to collect clinical data in order to expand the knowledge base of safety, efficacy and functionality of the Iberis system in patients with resistant hypertension. A minimum of 30 patients will be enrolled in Europe
Study Type
OBSERVATIONAL
Enrollment
18
Clinical Center of Serbia
Belgrade, Serbia
Hospital Galdakao
Galdakao, Spain
Blood Pressure (BP) Measurements
Office BP; Ambulatory BP; Home BP
Time frame: Up to 5 year FU
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.